Saral Gupta is a pharmaceutical strategy and market access leader serving as Director of Market Access & Pricing at Pfizer, where he focuses on advancing healthcare access, pricing strategy, and commercial effectiveness within India’s evolving pharmaceutical landscape. With over 14 years of experience in pharmaceutical data analytics, business strategy consulting, and commercial operations, he brings a strong combination of analytical expertise, strategic thinking, and business leadership to addressing complex healthcare challenges. His professional journey reflects a commitment to using data-driven insights and innovative commercial approaches to strengthen business performance while supporting broader objectives around patient access and affordability.

Since joining Pfizer in 2017 as Lead – Sales Services – Strategy, Saral has progressed through multiple leadership roles spanning sales force effectiveness, healthcare professional and patient engagement, incentive compensation, and commercial strategy. He has also led incentive compensation across Africa, the Middle East, India, and Asia Pacific, gaining experience in aligning commercial frameworks across diverse healthcare markets. Before joining Pfizer, he worked with IQVIA, formerly IMS Health, as a consultant and senior consultant, advising pharmaceutical companies on commercial due diligence, growth strategy, go-to-market planning, market intelligence, forecasting, and primary market research. Earlier, he worked with ZS Associates, developing expertise in revenue forecasting, market research, and strategic planning for pharmaceutical markets.

In his current role, Saral’s work sits at the intersection of pricing, market access, and commercial strategy. These areas are critical to navigating the complexities of pharmaceutical markets, where sustainable business growth must be aligned with patient needs, affordability, and the availability of innovative therapies. His professional focus complements Pfizer India’s broader efforts to expand access through patient assistance programs, digital solutions, and partnerships that help address barriers to treatment.

Pfizer India
+1

Saral holds a Bachelor of Technology in Chemical Engineering and a Master’s degree in Technology in Process and Design Engineering from the Indian Institute of Technology Delhi. He has also undertaken the Pfizer EDGE Essentials leadership program with Harvard Business Impact Education. Combining technical training with extensive experience in pharmaceutical consulting and commercial leadership, he brings an evidence-led perspective to market access and pricing, contributing to the wider objective of making healthcare solutions more accessible while supporting sustainable growth in the pharmaceutical industry.